📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1a and compromises development and progression of acute myeloid leukemia. (2024)

First Author: Lawson H

Attributed to: Structural, Mechanistic and Functional Studies on Protein Hydroxylases funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s43018-024-00761-w

PubMed Identifier: 38637657

Publication URI: http://europepmc.org/abstract/MED/38637657

Type: Journal Article/Review

Volume: 5

Parent Publication: Nature cancer

Issue: 6

ISSN: 2662-1347